Melissa E Weinberg1, Peter Bacchetti, Robert J Rushakoff. 1. Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California San Francisco, San Francisco, California 94115 , USA.
Abstract
OBJECTIVE: The aim was to determine if frequently repeated glucose measurements mandated by an inpatient protocol led to falsely elevated reported rates of both hypo- and hyperglycemia. METHODS: In our academic medical center, a mandatory standardized subcutaneous insulin order form and protocol was implemented in May 2006. We analyzed point-of-care blood glucose (BG) measurements collected on all medical/surgical wards during the month of August in both 2005 and 2006 by all BGs measured, by patient admission, and by monitored patient-day. We then repeated all analyses using an algorithm that excluded BG values if another BG was measured less than 5 minutes later or 5-60 minutes earlier. RESULTS: In 2005 versus 2006, there were 7034 versus 8016 glucoses measured in 397 versus 389 patients over 1704 versus 1710 patient days, respectively. Analyses based on patient-day balanced differences in BG measurement frequency and patient length of stay. In both years, failure to exclude repeat values overestimated both the proportion of patient days with hypoglycemia (3.5% versus 1.8% in 2005, p = .003; 2.6% versus 1.3% in 2006, p = .007) and severe hyperglycemia (9.3% versus 7.4% in 2005, p = .09; 7.7% versus 5.9% in 2006, p = .08). Mean, median, and proportion of patient-day means within our target range (80-150 mg/dl) were not significantly different. CONCLUSIONS: Glucometric reports should exclude repeated BG measurements from a single clinical episode of hypo- or hyperglycemia in order to accurately reflect inpatient glycemic control. (c) 2010 Diabetes Technology Society.
OBJECTIVE: The aim was to determine if frequently repeated glucose measurements mandated by an inpatient protocol led to falsely elevated reported rates of both hypo- and hyperglycemia. METHODS: In our academic medical center, a mandatory standardized subcutaneous insulin order form and protocol was implemented in May 2006. We analyzed point-of-care blood glucose (BG) measurements collected on all medical/surgical wards during the month of August in both 2005 and 2006 by all BGs measured, by patient admission, and by monitored patient-day. We then repeated all analyses using an algorithm that excluded BG values if another BG was measured less than 5 minutes later or 5-60 minutes earlier. RESULTS: In 2005 versus 2006, there were 7034 versus 8016 glucoses measured in 397 versus 389 patients over 1704 versus 1710 patient days, respectively. Analyses based on patient-day balanced differences in BG measurement frequency and patient length of stay. In both years, failure to exclude repeat values overestimated both the proportion of patient days with hypoglycemia (3.5% versus 1.8% in 2005, p = .003; 2.6% versus 1.3% in 2006, p = .007) and severe hyperglycemia (9.3% versus 7.4% in 2005, p = .09; 7.7% versus 5.9% in 2006, p = .08). Mean, median, and proportion of patient-day means within our target range (80-150 mg/dl) were not significantly different. CONCLUSIONS: Glucometric reports should exclude repeated BG measurements from a single clinical episode of hypo- or hyperglycemia in order to accurately reflect inpatient glycemic control. (c) 2010 Diabetes Technology Society.
Authors: Philip A Goldberg; Janis E Bozzo; Prem G Thomas; Melinda M Mesmer; Olga V Sakharova; Martha J Radford; Silvio E Inzucchi Journal: Diabetes Technol Ther Date: 2006-10 Impact factor: 6.118
Authors: Susan S Braithwaite; Michelle M Buie; Cara L Thompson; Douglas F Baldwin; Maryanne D Oertel; Beverly A Robertson; Hetal P Mehrotra Journal: Endocr Pract Date: 2004 Mar-Apr Impact factor: 3.443
Authors: Guillermo E Umpierrez; Dawn Smiley; Ariel Zisman; Luz M Prieto; Andres Palacio; Miguel Ceron; Alvaro Puig; Roberto Mejia Journal: Diabetes Care Date: 2007-05-18 Impact factor: 19.112
Authors: Robert J Rushakoff; Joshua A Rushakoff; Zachary Kornberg; Heidemarie Windham MacMaster; Arti D Shah Journal: Curr Diab Rep Date: 2017-09 Impact factor: 4.810
Authors: Ronald Tamler; Dina E Green; Maria Skamagas; Tracy L Breen; Helen C Looker; Mark Babyatsky; Derek Leroith Journal: Diabetes Care Date: 2011-06-29 Impact factor: 19.112